It was the stuff of Silicon Valley dreams. Elizabeth Holmes dropped out of Stanford University to launch the blood testing disruptor Theranos and built it to a $9 billion valuation. But the tech adage “fake it until you make it” didn’t quite work for this medical device startup, and charges that the devices didn’t work mounted. Holmes and Ramesh Balwani, her onetime business and romantic partner, were indicted with 12 counts of wire fraud and conspiracy to commit wire fraud. In this episode, Stanford Law School Professor Robert Weisberg, a criminal law expert, discusses the trial, which began in September, the prosecution, the defense, and the larger implications of the case.